EpCAM expression as determined by publicly available gene array data is significantly lower in Basal B human breast cancer cell lines, which exhibit enhanced mesenchymal-like features, than in the Luminal and Basal A subgroups (Figure 1A) [64,65]. The gene discussed is EPCAM; the disease is breast carcinoma.